IGF2BP3 and neoplasm: Additionally, the expression of most of the regulators influences the tumor T feature of KIRC, LIHC, PRAD, STAD and THCA, especially IGF2BP1 in BRCA; IGF2BP2, IGF2BP3, LRPPRC, and METTL14 in KIRC; and IGF2BP3 in KIRP (Figure 2E).